Request for Covid-19 Impact Assessment of this Report
Market Segmentation
Global Healthcare IT Market can be segmented as follows:
By product and Services
--> Healthcare Provider Solutions - Clinical & nonclinical Solutions
--> Electronic Medical Records Systems
--> ePrescribing Solutions
--> Radiology Information Systems
--> Radiation Dose Management
--> Healthcare IT Integration Systems
--> Infection Surveillance Solutions
--> Pharmacy Information Systems
--> Medication Management Systems
--> Healthcare Analytics software including CRM
--> HCIT Outsourcing Services
By Component
--> Services
--> Software
--> Hardware
By End User
--> Healthcare Providers - Hospitals, Ambulatory Care Centers, Pharmacies and Diagnostic And Imaging Centers
--> Private & Public Healthcare Players along with the Third Party Administrators, Research centres and Government Institutions
Regional/Geographic Analysis
Geographically, the global healthcare IT market is distributed majorly over North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America, comprising Canada and the U.S., accounts for the largest share of the market. This large share of this region is attributed to the high adoption rate of HCIT technologies, the stringent legislations, and regulatory requirements regarding patient safety, accreditation requirements regarding healthcare programs and the presence of major IT companies across this area.
However, amongst the fastest growing markets, the Asia-Pacific region tops the list. Accelerated economic growth of countries, growing consumerism in the healthcare industry and the need to control the soaring healthcare costs are the key factors responsible for providingthe necessary boost to the global healthcare IT market.
Key Players
Key players in the Global Healthcare IT market are GE Healthcare (UK),United Healthcare Group(U.S.), McKesson Corporation (U.S.), Athenahealth, Inc. (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Epic Systems Corporation (U.S.), Cerner Corporation (U.S.) and Infor, Inc. (U.S.).
Other players in the value chain include IBM, Wipro Technologies,3M health Information Systems, Wolters KluwerConifer Health Solutions, Kronos Incorporated, Orian Health, CSI Healthcare IT and Syntel Inc.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...